Palatin Technologies' CEO Discusses F4Q12 Results - Earnings Call Transcript

Palatin Technologies, Inc. (PTN)

F4Q12 Earnings Call

September 11, 2012 11:00 a.m. ET


Carl Spana - President and Chief Executive Officer

Steve Wills - Chief Financial and Operating Officer, Executive Vice President

Jeffrey Edelson - Chief Medical Officer


Joseph Pantginis - Roth Capital Partners

Rahul Jasuja - Noble Financial Capital Markets



Good morning, ladies and gentlemen, and welcome to the Palatin Technologies Fourth Quarter Fiscal Year End for 2012 Call. As a reminder, this call is being recorded.

Before we begin our remarks, I would like to remind you that statements by Palatin that are not historical facts may be forward-looking statements. These statements are based on assumptions that may or may not prove to be accurate and the actual results could differ materially from those anticipated due to a variety of risks and uncertainties discussed in the company’s most recent filings with the Securities and Exchange Commission. Please consider such risks and uncertainties carefully in evaluating these forward-looking statements and Palatin’s prospects.

Now I would like to introduce your host for today’s call, Dr. Carl Spana, President and Chief Executive Officer of Palatin Technologies. Please go ahead, sir.

Carl Spana

Thank you. Good morning. I’m Carl Spana, President and CEO of Palatin Technologies. With me on the call today is Steve Wills, our Chief Financial and Operating Officer, and Executive Vice President; and Dr. Jeffrey Edelson, our Chief Medical Officer.

On today’s call we will be providing updates on our product programs and financial results. To begin, Steve Wills will provide an update on our fiscal fourth quarter 2012 financial results. Steve?

If you liked this article you might like

How to Trade Today's Most Active Stocks -- Ford, Palatin, More

Palatin Female Libido-Boosting Shot Fails Crucial Sex Frequency Test

Insider Trading Alert - AEL, PTN And BSX Traded By Insiders

Palatin Technologies (PTN) Stock Up After FDA Approval of 'Female Viagra'

Palatin Technologies (PTN) Stock Climbing on FDA Approval of 'Female Viagra'